- Home
- Publications
- Publication Search
- Publication Details
Title
A Comprehensive Review of Drug–Drug Interactions with Metformin
Authors
Keywords
Metformin, Topiramate, Sitagliptin, Aliskiren, Rabeprazole
Journal
CLINICAL PHARMACOKINETICS
Volume 54, Issue 8, Pages 811-824
Publisher
Springer Nature
Online
2015-05-05
DOI
10.1007/s40262-015-0270-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes
- (2015) James Flory et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone
- (2015) Tore Bjerregaard Stage et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A twin study of the trough plasma steady-state concentration of metformin
- (2015) Tore B. Stage et al. Pharmacogenetics and Genomics
- Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
- (2015) J. B. Sussman et al. BMJ-British Medical Journal
- Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
- (2015) J. B. Sussman et al. BMJ-British Medical Journal
- Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers
- (2014) Sung Kweon Cho et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects
- (2014) Dongseong Shin et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine
- (2014) Susanne Johansson et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetic Interaction Between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-label, 3-period, Crossover, Multiple-dose Study
- (2014) Donghwan Lee et al. CLINICAL THERAPEUTICS
- Pharmacokinetic interactions between topiramate and pioglitazone and metformin
- (2014) Prasarn Manitpisitkul et al. EPILEPSY RESEARCH
- N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin–trimethoprim interaction
- (2014) Fabian Müller et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The effect of voglibose on the pharmacokinetics of metformin in healthy Korean subjects
- (2014) Ho-Sook Kim et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1
- (2014) Liping Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects
- (2014) S. Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Metformin use decreases the anticoagulant effect of phenprocoumon
- (2014) J. C. F. Wijnen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects
- (2014) Jian Zong et al. Journal of the International AIDS Society
- Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
- (2014) Kaixin Zhou et al. Lancet Diabetes & Endocrinology
- Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
- (2013) Mladen V. Tzvetkov et al. BIOCHEMICAL PHARMACOLOGY
- Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters
- (2013) Barbara Grün et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Concomitant Administration of Trospium Chloride Extended Release on the Steady-State Pharmacokinetics of Metformin in Healthy Adults
- (2013) Michael G. Oefelein et al. CLINICAL DRUG INVESTIGATION
- Pregnane X Receptor Agonists Impair Postprandial Glucose Tolerance
- (2013) J Rysä et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Variation and Metformin Response
- (2013) Suning Chen et al. CURRENT DRUG METABOLISM
- The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects
- (2013) Yi Ding et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Severe Lactic Acidosis and Acute Pancreatitis Associated with Cimetidine in a Patient with Type 2 Diabetes Mellitus Taking Metformin
- (2013) Ji Ho Seo et al. INTERNAL MEDICINE
- Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics
- (2013) Frantisek Staud et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3
- (2013) Britta Haenisch et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Pharmacogenetics of Oral Antidiabetic Drugs
- (2013) Matthijs L. Becker et al. International Journal of Endocrinology
- Metformin and intravenous contrast
- (2012) M. O. Baerlocher et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Combination Treatment With Ipragliflozin and Metformin: A Randomized, Double-Blind, Placebo-Controlled Study in Patients With Type 2 Diabetes Mellitus
- (2012) Stephan A. Veltkamp et al. CLINICAL THERAPEUTICS
- Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects
- (2012) Donghoon Shin et al. CURRENT MEDICAL RESEARCH AND OPINION
- Disposition of metformin: Variability due to polymorphisms of organic cation transporters
- (2011) Oliver Zolk ANNALS OF MEDICINE
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Rifampin Enhances the Glucose-Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants
- (2011) S K Cho et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects
- (2011) H Kusuhara et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects
- (2011) C. G. Patel et al. DIABETES OBESITY & METABOLISM
- Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
- (2011) X. Stephenne et al. DIABETOLOGIA
- Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects
- (2011) J.-F. Rocha et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects
- (2011) A. Karim et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Profiling of a Prescription Drug Library for Potential Renal Drug–Drug Interactions Mediated by the Organic Cation Transporter 2
- (2011) Yasuto Kido et al. JOURNAL OF MEDICINAL CHEMISTRY
- Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins
- (2011) T. Minematsu et al. MOLECULAR CANCER THERAPEUTICS
- Oxybutynin and trospium are substrates of the human organic cation transporters
- (2011) Birger Wenge et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
- (2011) Anne T. Nies et al. PLoS One
- Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations
- (2010) J König et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients
- (2010) Jianke Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects
- (2010) S. Kasichayanula et al. DIABETES OBESITY & METABOLISM
- Reduced Renal Clearance of a Zwitterionic Substrate Cephalexin in Mate1-Deficient Mice
- (2010) S. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
- (2010) Ligong Chen et al. Pharmacogenetics and Genomics
- Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions
- (2010) G Ahlin et al. PHARMACOGENOMICS JOURNAL
- Sitagliptin attenuates metformin-mediated AMPK phosphorylation through inhibition of organic cation transporters
- (2010) Min-Koo Choi et al. XENOBIOTICA
- Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes
- (2009) Yan-Ling He et al. CURRENT MEDICAL RESEARCH AND OPINION
- Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects
- (2009) E. U. Graefe-Mody et al. CURRENT MEDICAL RESEARCH AND OPINION
- Interaction of beta-blockers with the renal uptake transporter OCT2
- (2009) I. Bachmakov et al. DIABETES OBESITY & METABOLISM
- Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts
- (2009) Gillian E. Caughey et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser
- (2009) O. Zolk et al. DRUG METABOLISM AND DISPOSITION
- Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells
- (2009) M. Tsuda et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin?
- (2008) Eileen Y. Y. Sung et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects
- (2008) Sujata Vaidyanathan et al. CURRENT MEDICAL RESEARCH AND OPINION
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Relationship between Drug/Metabolite Exposure and Impairment of Excretory Transport Function
- (2008) M. J. Zamek-Gliszczynski et al. DRUG METABOLISM AND DISPOSITION
- Mechanisms Underlying Saturable Intestinal Absorption of Metformin
- (2008) W. R. Proctor et al. DRUG METABOLISM AND DISPOSITION
- Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1–3in vitroand implications for drug–drug interactions
- (2008) K.-I. Umehara et al. XENOBIOTICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search